Alejandro Camba-Hernandez
Santa Cruz De Tenerife, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Journal: Alimentary pharmacology & therapeutics
Published: March 28, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
Journal: United European gastroenterology journal
Published: February 01, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.
Journal: Therapeutic advances in gastroenterology
Published: January 28, 2026
Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.
Journal: Gastroenterologia y hepatologia
Published: December 21, 2025
The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 13, 2025
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.
Journal: Therapeutic advances in gastroenterology
Published: October 14, 2025
Assessing inflammatory bowel disease monitoring procedures in Spain: insights from the IBD-PODCAST study.
Journal: Revista espanola de enfermedades digestivas
Published: June 27, 2025
Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease.
Journal: Journal of clinical medicine
Published: September 11, 2024
Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: August 24, 2024
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.
Journal: The American journal of gastroenterology
Published: June 07, 2024
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: June 07, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU.
Journal: Journal of medical Internet research
Published: June 03, 2024
Last Updated: 09/26/2026